Physical Activity in Cardiac Implantable Electronic Device Recipients During the COVID-19 Pandemic

Abhishek J Deshmukh1, Camden Harrell2, Jacob Hicks2

  • 1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

Insights

Physical activity (PA) significantly decreased in patients with cardiac implantable electronic devices (CIEDs) during the COVID-19 pandemic. This reduction in PA was observed across all demographics and device types in 2020 compared to 2019.

Area of Science:

  • Cardiology
  • Public Health
  • Biomedical Engineering

Background:

  • The COVID-19 pandemic has impacted lifestyle behaviors globally.
  • Understanding the effects on patients with cardiac implantable electronic devices (CIEDs) is crucial for cardiovascular health.
  • Physical activity (PA) is a key determinant of cardiovascular outcomes.

Purpose of the Study:

  • To quantify the changes in physical activity (PA) levels among patients with CIEDs during the COVID-19 pandemic.
  • To compare PA levels in 2020 with the pre-pandemic period of 2019.

Main Methods:

  • Retrospective analysis of PA data from the BIOTRONIK CERTITUDE Registry.
  • Comparison of mean daily and weekly PA from January to August 2020 versus the same period in 2019.
  • Inclusion of 21,660 patients with CIEDs.

Main Results:

  • A significant decline in daily PA was observed after the pandemic declaration in 2020.
  • The maximum mean reduction in PA was -24.5±36.3 minutes in April 2020 compared to 2019 (P<.0001).
  • PA remained lower throughout 2020 compared to 2019 across all patient subgroups.

Conclusions:

  • The COVID-19 pandemic led to a substantial decrease in daily physical activity for individuals with CIEDs.
  • Further research is needed to assess the long-term cardiovascular implications of this PA reduction.
Abstract

Related Concept Videos

Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.3K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
61
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27